Growth factors, their receptors and down-stream signaling proteins in human tumors: from experiment to clinical practice

по E. S. Gershtein, N. E. Kushlinsky
Опубликовано 2015-06-01

RANK/RANKL/OPG LIGAND-RECEPTOR SYSTEM AND ITS ROLE IN PRIMARY BONE NEOPLASMS (LITERATURE ANALYSIS AND OWN DATA)

по E. S. Gershtein, Yu. S. Timofeev, A. A. Zuev, N. E. Kushlinskii
Опубликовано 2015-12-01

CLINICAL PERSPECTIVES FOR STUDYING THE NUCLEAR TRANSCRIPTION FACTOR NF-κB IN BREAST CANCER

по E. S. Gershtein, A. M. Platova, V. P. Letyagin, N. E. Kushlinsky
Опубликовано 2014-09-01

Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer

по E. A. Kim, I. V. Vysotskaya, N. E. Kushlinsky, V. P. Letyagin, E. S. Gershtein
Опубликовано 2014-08-01

Modern approaches to kidney cancer immunotherapy

по N. E. Kushlinskii, M. V. Fridman, A. A. Morozov, E. S. Gershtein, Z. G. Kadagidze, V. B. Matveev
Опубликовано 2018-06-01

Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients

по E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii
Опубликовано 2020-12-01

Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations

по N. E. Kushlinskii, E. S. Gershtein, I. O. Goryatcheva, A. A. Morozov, A. A. Alferov, S. D. Bezhanova, I. A. Kazantseva, V. V. Bazaev, V. B. Matveev
Опубликовано 2019-03-01